摘要
Objective:To assess the role of pharmaceutical care in improving quality of life in type II diabetes mellitus patients in a tertiary care hospital.Methods:A prospective observational survey study was carried out for a period of 9 months in the General Medicine Department of the hospital.A total of 106 patients were enrolled and were randomly allocated to the control and intervention groups with 53 patients in each group.Version-19 of audit on diabetes-dependent quality of life questionnaire were provided to the patients,at the time of admission and during review.At the time of admission the intervention group was provided with counseling for diabetes and with patient information leaflets on the disease.A data entry format comprising the socio-demographic details of the patients,their medical and medication history,laboratory results,etc.were used to note down the patient details.The prescribing patterns of different oral hypoglycemic agents were noted.Results:A total of 106 patients were recruited,51%being male.Age ranged from 32 to 80 years with a mean age of 60.210±10.045.The duration since diagnosis was 5-10 years for most of the participants(67%),10-20 years for 29%and>20 years for the remaining.At the time of study,17.9%of participants were received insulin treatment,and 82.1%on oral hypoglycemic agent.The average weighted impact of intervention group which improved from-1.7526±0.5630 to-1.668800±0.048013 was found to be statistically significant.Thus the study showed that pharmaceutical care has a positive impact on the quality of life of diabetes patients.Conclusions:Quality of life is worsened in diabetes mellitus patients,particularly for the'freedom to eat'domain,indicating that an intervention to improve dietary freedom might be a good way of improving quality of life.The study also showed that patient counseling played an important role in improving quality of life of diabetes patients.
